Polyphor AG secured its first licensing deal with its proprietary Protein Epitope Mimetic (PEM) technology, an alliance in ophthalmology with Allergan Inc., worth up to $68 million. (BioWorld International)

No Abstract BioWorld International CorrespondentPARIS - Two French biotech firms, Cellectis SA and Genomic Vision SA, have launched a joint project for the development of a revolutionary treatment for HIV and herpes.